Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Controlling dengue with vaccines in Thailand.

Chao DL, Halstead SB, Halloran ME, Longini IM Jr.

PLoS Negl Trop Dis. 2012;6(10):e1876. doi: 10.1371/journal.pntd.0001876. Epub 2012 Oct 25.

2.

Impact of combined vector-control and vaccination strategies on transmission dynamics of dengue fever: a model-based analysis.

Knerer G, Currie CS, Brailsford SC.

Health Care Manag Sci. 2015 Jun;18(2):205-17. doi: 10.1007/s10729-013-9263-x. Epub 2013 Dec 27.

PMID:
24370922
3.

Simulations to compare efficacies of tetravalent dengue vaccines and mosquito vector control.

Thavara U, Tawatsin A, Nagao Y.

Epidemiol Infect. 2014 Jun;142(6):1245-58. doi: 10.1017/S0950268813001866. Epub 2013 Aug 8.

4.

A role for vector control in dengue vaccine programs.

Christofferson RC, Mores CN.

Vaccine. 2015 Dec 10;33(50):7069-74. doi: 10.1016/j.vaccine.2015.09.114. Epub 2015 Oct 21.

PMID:
26478199
5.

Potential opportunities and perils of imperfect dengue vaccines.

Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Schwartz IB, Burke DS, Cummings DA.

Vaccine. 2014 Jan 16;32(4):514-20. doi: 10.1016/j.vaccine.2013.11.020. Epub 2013 Nov 19.

6.
7.

Fine scale spatiotemporal clustering of dengue virus transmission in children and Aedes aegypti in rural Thai villages.

Yoon IK, Getis A, Aldstadt J, Rothman AL, Tannitisupawong D, Koenraadt CJ, Fansiri T, Jones JW, Morrison AC, Jarman RG, Nisalak A, Mammen MP Jr, Thammapalo S, Srikiatkhachorn A, Green S, Libraty DH, Gibbons RV, Endy T, Pimgate C, Scott TW.

PLoS Negl Trop Dis. 2012;6(7):e1730. doi: 10.1371/journal.pntd.0001730. Epub 2012 Jul 17.

8.

Points for Consideration for dengue vaccine introduction - recommendations by the Dengue Vaccine Initiative.

Lim JK, Lee YS, Wilder-Smith A, Thiry G, Mahoney R, Yoon IK.

Expert Rev Vaccines. 2016;15(4):529-38. doi: 10.1586/14760584.2016.1129279. Epub 2016 Jan 6. Review.

PMID:
26651238
9.

Projected Impact of Dengue Vaccination in Yucatán, Mexico.

Hladish TJ, Pearson CA, Chao DL, Rojas DP, Recchia GL, Gómez-Dantés H, Halloran ME, Pulliam JR, Longini IM.

PLoS Negl Trop Dis. 2016 May 26;10(5):e0004661. doi: 10.1371/journal.pntd.0004661. eCollection 2016 May.

10.

[Dengue fever: from disease to vaccination].

Teyssou R.

Med Trop (Mars). 2009 Aug;69(4):333-4. French.

PMID:
19725380
11.

Economic impact of dengue illness and the cost-effectiveness of future vaccination programs in Singapore.

Carrasco LR, Lee LK, Lee VJ, Ooi EE, Shepard DS, Thein TL, Gan V, Cook AR, Lye D, Ng LC, Leo YS.

PLoS Negl Trop Dis. 2011 Dec;5(12):e1426. doi: 10.1371/journal.pntd.0001426. Epub 2011 Dec 20.

12.

Financing dengue vaccine introduction in the Americas: challenges and opportunities.

Constenla D, Clark S.

Expert Rev Vaccines. 2016;15(4):547-59. doi: 10.1586/14760584.2016.1134329. Epub 2016 Jan 22. Review.

PMID:
26690087
13.

Spatial dimensions of dengue virus transmission across interepidemic and epidemic periods in Iquitos, Peru (1999-2003).

Liebman KA, Stoddard ST, Morrison AC, Rocha C, Minnick S, Sihuincha M, Russell KL, Olson JG, Blair PJ, Watts DM, Kochel T, Scott TW.

PLoS Negl Trop Dis. 2012;6(2):e1472. doi: 10.1371/journal.pntd.0001472. Epub 2012 Feb 21.

14.

Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment.

Ferguson NM, Rodríguez-Barraquer I, Dorigatti I, Mier-Y-Teran-Romero L, Laydon DJ, Cummings DA.

Science. 2016 Sep 2;353(6303):1033-1036.

PMID:
27701113
15.

The Potential Impact of Vaccination on the Dynamics of Dengue Infections.

Knipl D, Moghadas SM.

Bull Math Biol. 2015 Dec;77(12):2212-30. doi: 10.1007/s11538-015-0120-6. Epub 2015 Nov 19.

PMID:
26585748
16.

Spatial and temporal clustering of dengue virus transmission in Thai villages.

Mammen MP, Pimgate C, Koenraadt CJ, Rothman AL, Aldstadt J, Nisalak A, Jarman RG, Jones JW, Srikiatkhachorn A, Ypil-Butac CA, Getis A, Thammapalo S, Morrison AC, Libraty DH, Green S, Scott TW.

PLoS Med. 2008 Nov 4;5(11):e205. doi: 10.1371/journal.pmed.0050205.

17.

An outbreak of dengue virus serotype 1 infection in Cixi, Ningbo, People's Republic of China, 2004, associated with a traveler from Thailand and high density of Aedes albopictus.

Xu G, Dong H, Shi N, Liu S, Zhou A, Cheng Z, Chen G, Liu J, Fang T, Zhang H, Gu C, Tan X, Ye J, Xie S, Cao G.

Am J Trop Med Hyg. 2007 Jun;76(6):1182-8.

PMID:
17556633
18.

Transmission dynamics of the four dengue serotypes in southern Vietnam and the potential impact of vaccination.

Coudeville L, Garnett GP.

PLoS One. 2012;7(12):e51244. doi: 10.1371/journal.pone.0051244. Epub 2012 Dec 10.

19.

DENGUE PATIENTS AT PHOTHARAM HOSPITAL: A CLINICAL TRIAL SITE OF DENGUE VACCINE.

Nunthanid S, Tiawilai A.

Southeast Asian J Trop Med Public Health. 2015;46 Suppl 1:11-6.

PMID:
26506727
20.

Live attenuated tetravalent dengue virus host range vaccine is immunogenic in African green monkeys following a single vaccination.

Briggs CM, Smith KM, Piper A, Huitt E, Spears CJ, Quiles M, Ribeiro M, Thomas ME, Brown DT, Hernandez R.

J Virol. 2014 Jun;88(12):6729-42. doi: 10.1128/JVI.00541-14. Epub 2014 Apr 2.

Supplemental Content

Support Center